In an important paper the Galen Institute is releasing today, Senior Fellow Doug Badger examines the role that employer-sponsored health insurance (ESI) plays in the larger U.S. health sector and offers considerations for policymakers contemplating replacing ESI with government-financed coverage. In “Replacing Employer-Sponsored Health Insurance with Government-Financed Coverage: Considerations for Policymakers,” Badger examines the history...
by Grace-Marie Turner — The Centers for Medicaid & Medicare Services is continuing the drumbeat of modernizing the two gargantuan programs it runs to generate more accountability, greater transparency, and provide better value for both patients and taxpayers. Administrator Seema Verma announced on Thursday a new proposed rule that would bring more accountability into...
Congress ordered the Centers for Medicare and Medicaid Services (CMS) to come up with a new payment system for the more than 400 million clinical laboratory tests that Medicare pays for each year so that prices would be more closely aligned with those paid by private insurers. But the new system relies on data...
President Trump’s plan to lower prescription drug costs uses a surgeon’s scalpel to address a range of issues, offering nearly 30 policy recommendations to modernize payment policies, weed out counter-productive regulations, improve price transparency, and expand competitive price negotiations. The plan reflects the complexity of the industry and the regulatory system that governs government approval...
President Trump delivered a major speech to describe steps his administration is taking to address the high cost of prescription drugs. Congress should be called on to fix two problems with the federal government’s largest prescription drug program: Medicare Part D. That program has made prescription medicines more affordable for millions of seniors, offering...